NeuroProof
Desconocido
SYNDEGEN: Synaptic dysfunction in Neurodegenerative Diseases
NEUROPROOF GMBH
participó en un
H2020:
H2020-MSCA-ITN-2016
Neurodegenerative diseases (NDDs) of aging are a growing burden on societies. Although studies on the degeneration of neurons have been a ma...
2016-08-31 - 2021-06-30 | Financiado
2016-08-31 - 2021-06-30 | Financiado
PREDICT-IV: Profiling the toxicity of new drugs a non animal based approach integrating toxicodynamics and biok...
NEUROPROOF GMBH
participó en un
FP7:
The overall aim of Predict-IV is to develop strategies to improve the assessment of drug safety in the early stage of development and late d...
Financiado
Financiado
ENAROMATIC: European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control
NEUROPROOF GMBH
participó en un
FP7:
The specificity of odor recognition by Anopheles gambiae odorant binding proteins (OBPs) and odorant receptors (ORs) will be investigated an...
Financiado
Financiado
* No se disponen de datos de la empresa actual.